blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1912992

EP1912992 - XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.08.2010
Database last updated on 15.06.2024
Most recent event   Tooltip13.08.2010Application deemed to be withdrawnpublished on 15.09.2010  [2010/37]
Applicant(s)For all designated states
GlaxoSmithKline LLC
One Franklin Plaza
200 North 16th Street
Philadelphia, PA 19102 / US
[N/P]
Former [2010/13]For all designated states
GlaxoSmithKline LLC
One Franklin Plaza 200 North 16th Street
Philadelphia, PA 19102 / US
Former [2008/17]For all designated states
SmithKline Beecham Corporation
One Franklin Plaza P.O. Box 7929
Philadelphia, PA 19101 / US
Inventor(s)01 / HATLEY, Richard, Jonathan, Daniel
GlaxoSmithKline Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY / GB
02 / HEER, Jag, Paul
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
03 / LIDDLE, John
GlaxoSmithKline Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY / GB
04 / MASON, Andrew, McMurtrie
GlaxoSmithKline Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY / GB
05 / PINTO, Ivan, Leo
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
06 / RAHMAN, Shahzad, Sharooq
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
07 / SMITH, Ian, Edward, David
GlaxoSmithKline Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY / GB
 [2008/17]
Representative(s)Reed, Michael Antony, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2008/17]Reed, Michael Antony, et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date06776699.808.08.2006
[2008/17]
WO2006EP07869
Priority number, dateGB2005001646410.08.2005         Original published format: GB 0516464
GB2006000773619.04.2006         Original published format: GB 0607736
GB2006001456921.07.2006         Original published format: GB 0614569
[2008/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007017262
Date:15.02.2007
Language:EN
[2007/07]
Type: A1 Application with search report 
No.:EP1912992
Date:23.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 15.02.2007 takes the place of the publication of the European patent application.
[2008/17]
Search report(s)International search report - published on:EP15.02.2007
ClassificationIPC:C07D473/06, C07D473/04, A61K31/495, A61P3/00, A61P9/00
[2008/17]
CPC:
C07D473/04 (EP,KR,US); C07D473/06 (EP,KR,US); A61K31/495 (KR);
A61P1/14 (EP); A61P13/12 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P5/50 (EP); A61P7/02 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/08 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/17]
Extension statesALNot yet paid
BANot yet paid
HR30.01.2008
MKNot yet paid
RSNot yet paid
TitleGerman:XANTHINDERIVATE ALS SELEKTIVE HM74A-AGONISTEN[2008/17]
English:XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS[2008/17]
French:DERIVES DE XANTHINE EN TANT QU'AGONISTES HM74A SELECTIFS[2008/17]
Entry into regional phase30.01.2008National basic fee paid 
30.01.2008Designation fee(s) paid 
30.01.2008Examination fee paid 
Examination procedure30.01.2008Amendment by applicant (claims and/or description)
30.01.2008Examination requested  [2008/17]
23.09.2009Despatch of a communication from the examining division (Time limit: M04)
04.02.2010Application deemed to be withdrawn, date of legal effect  [2010/37]
30.03.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/37]
Fees paidRenewal fee
08.08.2008Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.08.200904   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO03004496  (NOVO NORDISK AS [DK]) [A] 1-19 * the whole document *;
 [A]EP1338595  (EISAI CO LTD [JP]) [A] 1-19* the whole document *;
 [A]WO2005016870  (SMITHKLINE BEECHAM CORP [US], et al) [A] 1-19 * the whole document *;
 [A]  - ARCH J R S ET AL, "INHIBITION OF TYPE 4 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE BY 8-CHLOROXANTHINES", ARCHIV DER PHARMAZIE, VCH VERLAGSGESELLSCHAFT MBH, WEINHEIM, DE, (1996), vol. 329, no. 4, ISSN 0365-6233, pages 205 - 208, XP008046719 [A] 1-19 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.